Czechia· CZ-0258019

ENDIARON

A other intestinal antiinfectives product containing chloroxine, registered in Czechia by Opella Healthcare Czech s.r.o., Praha.

ATC A07AX

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedENDIARONATCA07AXREGISTER NO.CZ-0258019PACKS LISTED0CHECKEDSeptember 28, 2026

The record

At a glance

SÚKL (Czech Republic)
Active substance
CHLOROXINE
Manufacturer
Opella Healthcare Czech s.r.o., Praha
Country
Czechia (CZ)
ATC code
A07AX
ATC class
Other intestinal antiinfectives
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A07AX

Other intestinal antiinfectives, as other registers publish it.

All chloroxine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e60f0741-9efa-4f99-8f44-647feb32ad95
GET /v1/drugs/e60f0741-9efa-4f99-8f44-647feb32ad95?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "250MG",
  "pack_size": "20",
  "substance": "CHLOROXINE",
  "cz_kod_sukl": "0258019",
  "product_type": "CH",
  "substance_codes": "2112",
  "registration_state": "R",
  "registration_number": "42/101/74-C"
}

See everything about chloroxine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.